Initial procedure, (b)(6) 2008 : left total hip replacement.Patient was originally implanted with size 46 asr unipolar femoral component, asrtaper sleeve adaptor and size 52 asr total acetabular component.Preoperative diagnosis-severe left coxarthrosis (prior to (b)(6) 2008 surgery).It was reported by legal that the patient was revised on (b)(6) 2015 patient had a total left hip revision.The pre-op diagnosis was a pseudotumor and contained bone loss (left femur and left acetabulum).The surgery involved removal of the left hip pseudotumor, revision of the acetabular cavity, total left hip replacement.Allograft-left acetabulum and left femur.(b)(6) 2018: medical records and translated document received.After review of medical records for mdr reportability, it was indicated that the patient was revised due to pseudotumor type tissue reaction to a total left hip replacement with contained bone loss.The revision notes report that when they opened the junction between the scar tissue and the posterior part of the greater trochanter, a large amount of greenish serous fluid was found.An abnormal tissue reaction with greenish hyperplastic tissue in the back of the hip prosthesis and brownish hyperplastic tissue in front was also observed.Presence of metallosis at the junction between the head, neck and femoral prosthesis was also noted.It was observed that on the posterior side of the femoral prosthesis, there was an enormous cavity which required an allograft.It was also reported that there were some contained bone loss in the anterior and inferior areas of the acetabular component and these areas were cleaned with a curette to remove poor-quality tissue.Clinic visits show that patient had intermittent pain, discomfort and metallosis.Ultrasound confirms fluid buildup.Lab results also indicate elevated c-reactive protein, chromium and cobalt ion levels.
|
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.Product complaint # :(b)(4).Investigation summary : the asr platform was voluntarily recalled from the market in august 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken.The investigation regarding the root cause(s) and/or corrective actions was conducted under mdd capa-001226.Ongoing post market surveillance is conducted per our procedures for this product.
|